Receive 30% off all Monoclonal IHC antibodies with code "MONO-IHC-30"! Offer valid for US customers and available internationally through distributors.

Abemaciclib

Overview
Catalog # bs-83416c-50mg
Product Name Abemaciclib
Specifications
Storage Buffer Off-white solid
Storage Condition -20°C
Target
Product Information Abemaciclib (1231930-82-7) is a potent and selective CDK4/6 inhibitor (IC50 = 2 nM and 10 nM respectively).1 It caused G1 cell cycle arrest in colo-205 colorectal cells, MDA-MB-361 breast cancer cells, and MV4-11 AML cells. Abemaciclib was also active in several human tumor xenograft models. It displayed efficacy in patients with various solid tumors including breast cancer, non-small cell lung cancer, glioblastoma, melanoma, colorectal cancer, and hormone receptor-positive breast cancer.2 Abemaciclib induced a T cell inflamed tumor microenvironment and enhanced the efficacy of PD-L1 checkpoint blockade in MCF-7 breast cancer cells.3 FDA approved for the treatment of advanced breast cancers.
Description CAS Number: 1231930-82-7

Chemical Name: CDK 4/6 inhibitor

Molecular Weight: 602.70

Formula: C27H32F2N8·CH3SO3H

Solubility: DMSO > 25 mg/ml Water > 25 mg/ml

Physical Properties: Off-white solid

Purity: >98% by HPLC NMR (Conforms)